Vinva Investment Management Ltd Acquires 7,837 Shares of MetLife, Inc. $MET

Vinva Investment Management Ltd increased its holdings in MetLife, Inc. (NYSE:MET) by 19.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,631 shares of the financial services provider’s stock after buying an additional 7,837 shares during the quarter. Vinva Investment Management Ltd’s holdings in MetLife were worth $3,909,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in MET. Brighton Jones LLC increased its stake in shares of MetLife by 9.0% in the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after purchasing an additional 351 shares in the last quarter. Caxton Associates LLP bought a new position in shares of MetLife in the first quarter worth about $307,000. Empowered Funds LLC lifted its position in shares of MetLife by 187.6% during the 1st quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock valued at $2,680,000 after buying an additional 21,771 shares in the last quarter. Sivia Capital Partners LLC bought a new position in shares of MetLife during the 2nd quarter valued at approximately $404,000. Finally, Golden State Wealth Management LLC increased its holdings in MetLife by 41.9% in the 2nd quarter. Golden State Wealth Management LLC now owns 667 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 197 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

MetLife Trading Down 1.5%

Shares of MET opened at $71.83 on Monday. The firm has a market cap of $46.84 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 0.66 and a beta of 0.76. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $85.00. The company has a 50 day simple moving average of $77.20 and a two-hundred day simple moving average of $78.72.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping the consensus estimate of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The firm had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter in the previous year, the firm earned $2.08 earnings per share. The company’s quarterly revenue was up 27.6% compared to the same quarter last year. On average, equities analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 3.2%. MetLife’s payout ratio is presently 48.30%.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

Analyst Ratings Changes

A number of research firms have commented on MET. Morgan Stanley decreased their target price on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Barclays set a $90.00 price objective on shares of MetLife in a research report on Thursday, January 8th. Wells Fargo & Company lowered their target price on shares of MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Weiss Ratings raised shares of MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 20th. Finally, UBS Group increased their price target on MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, MetLife currently has a consensus rating of “Buy” and a consensus price target of $94.18.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.